FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313492022> ?p ?o ?g. }

• W4313492022 abstract "A novel nano-formulation (NF) that sensitizes Acinetobacter baumannii (AB) to otherwise ineffective colistin is described in the present study. Infections due to multidrug resistant (MDR) AB represent a major therapeutic challenge, especially in situations of pre-existing colistin resistance (colR). Subsequently, boosting the effectiveness of colistin would be a better alternative tactic to treat AB infections rather than discovering a new class of antibiotics. We have previously demonstrated an NF comprising self-assembled guanidinium and ionic silver nanoparticles [AD-L@Ag(0)] to have anti-biofilm and bactericidal activity. We report NF AD-L@Ag(0) for the very first time for the potentiation of colistin in Gram-negative colistin-resistant bacteria. Our results implied that a combination of clinically relevant concentrations of colistin and AD-L@Ag(0) significantly decreased colistin-resistant AB bacterial growth and viability, which otherwise was elevated in the presence of only colistin. In this study, we have described various combinations of minimum inhibitory concentration (MIC) of colistin (MICcol, 1/2 MICcol, and 1/4 MICcol) and that of AD-L@Ag(0) [MICAD-L@Ag(0), 1/2 MICAD-L@Ag(0), and 1/4 MICAD-L@Ag(0)] and tested them against MDR AB culture. The results (in broth as well as in solid media) signified that AD-L@Ag(0) was able to potentiate the anti-microbial activity of colistin at sub-MIC concentrations. Furthermore, the viability and metabolic activity of bacterial cells were also measured by CTC fluorescence assay and ATP bioluminescence assay. The results of these assays were in perfect concordance with the scores of cultures (colony forming unit and culture turbidity). In addition, quantitative real-time PCR (qRT-PCR) was performed to unveil the expression of selected genes, DNAgyrA, DNAgyrB, and dac. These genes introduce negative supercoiling in the DNA, and hence are important for basic cellular processes. These genes, due to mutation, modified the Lipid A of bacteria, further resisting the uptake of colistin. Therefore, the expression of these genes was upregulated when AB was treated with only colistin, substantiating that AB is resistant to colistin, whereas the combinations of MICcol + MICAD-L@Ag(0) downregulated the expression of these genes, implying that the developed formulation can potentiate the efficiency of colistin. In conclusion, AD-L@Ag(0) can potentiate the proficiency of colistin, further enhancing colistin-mediated death of AB by putatively disrupting the outer membrane (OM) and facilitating bacterial death." @default.
• W4313492022 created "2023-01-06" @default.
• W4313492022 creator A5016617075 @default.
• W4313492022 creator A5017391319 @default.
• W4313492022 creator A5043242471 @default.
• W4313492022 creator A5047953186 @default.
• W4313492022 creator A5050462970 @default.
• W4313492022 creator A5055285646 @default.
• W4313492022 creator A5082040253 @default.
• W4313492022 creator A5082992565 @default.
• W4313492022 creator A5091470496 @default.
• W4313492022 date "2023-01-04" @default.
• W4313492022 modified "2023-10-18" @default.
• W4313492022 title "Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver" @default.
• W4313492022 cites W150404207 @default.
• W4313492022 cites W1735743396 @default.
• W4313492022 cites W1972945860 @default.
• W4313492022 cites W1982373493 @default.
• W4313492022 cites W1988595672 @default.
• W4313492022 cites W1998923975 @default.
• W4313492022 cites W1999833129 @default.
• W4313492022 cites W2006556863 @default.
• W4313492022 cites W2012858204 @default.
• W4313492022 cites W2016055522 @default.
• W4313492022 cites W2016211168 @default.
• W4313492022 cites W2016510762 @default.
• W4313492022 cites W2022792624 @default.
• W4313492022 cites W2028684543 @default.
• W4313492022 cites W2036526851 @default.
• W4313492022 cites W2039125980 @default.
• W4313492022 cites W2040963157 @default.
• W4313492022 cites W2051101891 @default.
• W4313492022 cites W2052899239 @default.
• W4313492022 cites W2053307446 @default.
• W4313492022 cites W2067997521 @default.
• W4313492022 cites W2069891666 @default.
• W4313492022 cites W2070123919 @default.
• W4313492022 cites W2088889988 @default.
• W4313492022 cites W2090749952 @default.
• W4313492022 cites W2098239999 @default.
• W4313492022 cites W2098983554 @default.
• W4313492022 cites W2105838577 @default.
• W4313492022 cites W2112191861 @default.
• W4313492022 cites W2115590616 @default.
• W4313492022 cites W2116245384 @default.
• W4313492022 cites W2122863748 @default.
• W4313492022 cites W2123918839 @default.
• W4313492022 cites W2126504345 @default.
• W4313492022 cites W2138023605 @default.
• W4313492022 cites W2138137693 @default.
• W4313492022 cites W2142775912 @default.
• W4313492022 cites W2143678351 @default.
• W4313492022 cites W214735427 @default.
• W4313492022 cites W2155122915 @default.
• W4313492022 cites W2158921004 @default.
• W4313492022 cites W2159435953 @default.
• W4313492022 cites W2162745520 @default.
• W4313492022 cites W2164032940 @default.
• W4313492022 cites W2171780940 @default.
• W4313492022 cites W2266412763 @default.
• W4313492022 cites W2315080166 @default.
• W4313492022 cites W2320103420 @default.
• W4313492022 cites W2326296772 @default.
• W4313492022 cites W2344157802 @default.
• W4313492022 cites W2460036646 @default.
• W4313492022 cites W2479080868 @default.
• W4313492022 cites W2513561128 @default.
• W4313492022 cites W2560546984 @default.
• W4313492022 cites W2593939403 @default.
• W4313492022 cites W2606416324 @default.
• W4313492022 cites W2617364164 @default.
• W4313492022 cites W2762722151 @default.
• W4313492022 cites W2779019546 @default.
• W4313492022 cites W2791136115 @default.
• W4313492022 cites W2884130168 @default.
• W4313492022 cites W2889157647 @default.
• W4313492022 cites W2899549732 @default.
• W4313492022 cites W2937306142 @default.
• W4313492022 cites W2947120985 @default.
• W4313492022 cites W2967918393 @default.
• W4313492022 cites W2971929062 @default.
• W4313492022 cites W2973143540 @default.
• W4313492022 cites W2979967103 @default.
• W4313492022 cites W3006824740 @default.
• W4313492022 cites W3015717458 @default.
• W4313492022 cites W3024354797 @default.
• W4313492022 cites W3030787643 @default.
• W4313492022 cites W3036595317 @default.
• W4313492022 cites W3083784660 @default.
• W4313492022 cites W3089234580 @default.
• W4313492022 cites W3095155494 @default.
• W4313492022 cites W3162363606 @default.
• W4313492022 cites W3216179038 @default.
• W4313492022 cites W4211056710 @default.
• W4313492022 cites W4220679621 @default.
• W4313492022 cites W4285818868 @default.
• W4313492022 cites W4288065238 @default.
• W4313492022 cites W4289517437 @default.
• W4313492022 doi "https://doi.org/10.3389/fmicb.2022.1006604" @default.
• W4313492022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36687622" @default.

• next